CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
64.45
-2.52 (-3.76%)
May 12, 2025, 3:36 PM - Market open
CVS Health Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for CVS Health stock have an average target of 75.14, with a low estimate of 62 and a high estimate of 84. The average target predicts an increase of 16.59% from the current stock price of 64.45.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CVS Health stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 6 | 5 | 5 | 5 | 3 |
| Buy | 7 | 7 | 8 | 8 | 8 | 8 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 16 | 16 | 16 | 16 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $82 → $84 | Strong Buy | Maintains | $82 → $84 | +30.33% | May 12, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $76 → $84 | Buy | Maintains | $76 → $84 | +30.33% | May 6, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $74 → $81 | Buy | Maintains | $74 → $81 | +25.68% | May 5, 2025 |
| UBS | UBS | Hold Maintains $67 → $71 | Hold | Maintains | $67 → $71 | +10.16% | May 2, 2025 |
| Barclays | Barclays | Buy Maintains $73 → $82 | Buy | Maintains | $73 → $82 | +27.23% | May 2, 2025 |
Financial Forecast
Revenue This Year
390.88B
from 370.66B
Increased by 5.45%
Revenue Next Year
407.29B
from 390.88B
Increased by 4.20%
EPS This Year
5.96
from 3.66
Increased by 62.92%
EPS Next Year
6.92
from 5.96
Increased by 15.98%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 422.6B | 444.7B | 481.5B | ||
| Avg | 390.9B | 407.3B | 431.5B | ||
| Low | 374.0B | 380.8B | 385.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.0% | 13.8% | 18.2% | ||
| Avg | 5.5% | 4.2% | 5.9% | ||
| Low | 0.9% | -2.6% | -5.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.83 | 8.06 | 9.45 | ||
| Avg | 5.96 | 6.92 | 7.94 | ||
| Low | 5.52 | 6.07 | 6.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 86.5% | 35.2% | 36.6% | ||
| Avg | 62.9% | 16.0% | 14.8% | ||
| Low | 50.7% | 1.8% | -10.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.